Inventor · disambiguated record
David Buttar
Also filed as: BUTTAR DAVID
11 granted patents·4 pending applications·45 citations·filing 2007–2023
88Inventor score
Top patents by PatentIndex Score
15 records- 0192US7737149B2N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereofASTRAZENECA AB·Filed 2007·Granted Jun 15, 2010·17 cites·3 claims
- 0290US8129391B2N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereofFOOTE KEVIN MICHAEL·Filed 2010·Granted Mar 6, 2012·12 cites·3 claims
- 0387US8604022B2N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereofFOOTE KEVIN MICHAEL·Filed 2012·Granted Dec 10, 2013·8 cites·4 claims
- 0483US11084827B2Triazolopyrimidine compounds and their use in treating cancerDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 10, 2021·1 cites·18 claims
- 0581US9688640B2Methods of treating cancer with a pyrazole derivativeASTRAZENECA AB·Filed 2015·Granted Jun 27, 2017·2 cites·3 claims
- 0680US9155727B2Chemical compoundsASTRAZENECA AB·Filed 2014·Granted Oct 13, 2015·5 cites·11 claims
- 0779US12503473B2Triazolopyrimidine compounds and their use in treating cancerDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2023·Granted Dec 23, 2025·0 cites·6 claims
- 0870US11851432B2Triazolopyrimidine compounds and their use in treating cancerDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2021·Granted Dec 26, 2023·0 cites·20 claims
- 0964US10301267B2CompoundsASTRAZENECA AB·Filed 2017·Granted May 28, 2019·0 cites·2 claims
- 1062US2014066455A1Novel compoundsASTRAZENECA AB·Filed 2013·Application pending·0 cites
- 1157US10130617B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Nov 20, 2018·0 cites·13 claims
- 1256US2019038607A1Chemical compoundsASTRAZENECA AB·Filed 2018·Application pending·0 cites
- 1354US9616050B2Chemical compoundsASTRAZENECA AB·Filed 2015·Granted Apr 11, 2017·0 cites·8 claims
- 1451US2009318468A1Pyrazole compounds 436ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1545US2008004302A1Novel CompoundsASTRAZENECA AB·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Buttar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →